Maplight Therapeutics, INC. (MPLT) — 10-K Filings
All 10-K filings from Maplight Therapeutics, INC.. Browse 1 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (1)
-
MapLight's Lead Drug Nears Key Phase 2 Readouts for Schizophrenia, ADP
— Mar 26, 2026 Risk: high
MapLight Therapeutics, Inc. (MPLT) is a clinical-stage biopharmaceutical company focused on CNS disorders, reporting no commercialized products and a limited op
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX